摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-(benzyloxy)phenyl)-4-(4-methoxyphenyl)-N-methylbut-3-yn-2-amine | 1262680-30-7

中文名称
——
中文别名
——
英文名称
1-(4-(benzyloxy)phenyl)-4-(4-methoxyphenyl)-N-methylbut-3-yn-2-amine
英文别名
4-(4-methoxyphenyl)-N-methyl-1-(4-phenylmethoxyphenyl)but-3-yn-2-amine
1-(4-(benzyloxy)phenyl)-4-(4-methoxyphenyl)-N-methylbut-3-yn-2-amine化学式
CAS
1262680-30-7
化学式
C25H25NO2
mdl
——
分子量
371.479
InChiKey
GYZDPGNXQFBJLE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.1
  • 重原子数:
    28
  • 可旋转键数:
    8
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    30.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(4-(benzyloxy)phenyl)-4-(4-methoxyphenyl)-N-methylbut-3-yn-2-amine三甲基氯硅烷silver nitrate三乙胺 作用下, 以 二氯甲烷乙腈 为溶剂, 反应 2.17h, 生成 (2Z,5Z)-benzyl 4-(4-(benzyloxy)benzyl)-2-((2-fluorobenzoyl)imino)-5-(4-methoxybenzylidene)-3-methylimidazolidine-1-carboxylate
    参考文献:
    名称:
    [EN] COMPOSITIONS AND METHODS COMPRISING 2-(ACYLAMINO)IMIDAZOLES
    [FR] COMPOSITIONS ET PROCÉDÉS COMPRENANT DES 2- (ACYLAMINO) IMIDAZOLES
    摘要:
    公开号:
    WO2015143240A3
  • 作为产物:
    描述:
    参考文献:
    名称:
    Synthesis of Naamidine A and Selective Access to N2-Acyl-2-aminoimidazole Analogues
    摘要:
    A short and scalable synthesis of naamidine A, a marine alkaloid with a selective ability to inhibit epidermal growth factor receptor (EGFR)-dependent cellular proliferation, has been achieved. A key achievement in this synthesis was the development of a regioselective hydroamination of a monoprotected propargylguanidine to deliver N-3-protected cyclic ene-guanidines. This permits the extension of this methodology to prepare N-2-acyl analogues in a fashion that obviates the troublesome acylation of the free 2-aminoimidazoles, which typically yields mixtures of N-2- and N-2,N-2-diacylated products.
    DOI:
    10.1021/acs.joc.5b01703
点击查看最新优质反应信息

文献信息

  • Concise and Diversity-Oriented Route toward Polysubstituted 2-Aminoimidazole Alkaloids and Their Analogues
    作者:Denis S. Ermolat'ev、Jitender B. Bariwal、Hans P. L. Steenackers、Sigrid C. J. De Keersmaecker、Erik V. Van der Eycken
    DOI:10.1002/anie.201004256
    日期:2010.12.3
    Alkaloids of the naamine family were synthesized from diverse propargylamines in just two steps (see scheme: R1=Me, R2=substituted benzyl, R3=Ar). Thus, the addition to a propargylamine of a carbodiimide generated in situ, silver(I)‐catalyzed intramolecular hydroamidation, and subsquent deprotection provide access to the heterocyclic core of numerous natural products and biologically active compounds
    纳胺家族的生物碱仅需两个步骤就可以由多种炔丙基胺合成(参见方案:R 1 = Me,R 2 =取代的苄基,R 3 = Ar)。因此,除了在炔丙基胺中原位生成的碳二亚胺之外,银(I)催化的分子内加氢酰胺化作用以及随后的脱保护作用也使人们可以接近许多天然产物和生物活性化合物的杂环核。Boc =叔丁氧羰基,Cbz =碳苄氧基。
  • Compositions and methods comprising 2-(acylamino)imidazoles
    申请人:Curza Global, LLC
    公开号:US10493061B2
    公开(公告)日:2019-12-03
    The present invention presents 2-(acylamino)imidazoles with therapeutic activity, including selective activity against cancer cells, and compositions comprising them. Methods of using and preparing the 2-(acylamino)imidazoles are also presented.
    本发明提出了具有治疗活性(包括对癌细胞的选择性活性)的 2-(酰氨基)咪唑以及包含它们的组合物。本发明还提出了使用和制备 2-(酰氨基)咪唑的方法。
  • COMPOSITIONS AND METHODS COMPRISING 2-(ACYLAMINO)IMIDAZOLES
    申请人:Curza Global LLC
    公开号:EP3119394B1
    公开(公告)日:2021-05-12
  • [EN] COMPOSITIONS AND METHODS COMPRISING 2-(ACYLAMINO)IMIDAZOLES<br/>[FR] COMPOSITIONS ET PROCÉDÉS COMPRENANT DES 2- (ACYLAMINO) IMIDAZOLES
    申请人:CURZA GLOBAL LLC
    公开号:WO2015143240A3
    公开(公告)日:2015-11-12
  • Synthesis of Naamidine A and Selective Access to N<sup>2</sup>-Acyl-2-aminoimidazole Analogues
    作者:Joseph B. Gibbons、Justin M. Salvant、Rachel M. Vaden、Ki-Hyeok Kwon、Bryan E. Welm、Ryan E. Looper
    DOI:10.1021/acs.joc.5b01703
    日期:2015.10.16
    A short and scalable synthesis of naamidine A, a marine alkaloid with a selective ability to inhibit epidermal growth factor receptor (EGFR)-dependent cellular proliferation, has been achieved. A key achievement in this synthesis was the development of a regioselective hydroamination of a monoprotected propargylguanidine to deliver N-3-protected cyclic ene-guanidines. This permits the extension of this methodology to prepare N-2-acyl analogues in a fashion that obviates the troublesome acylation of the free 2-aminoimidazoles, which typically yields mixtures of N-2- and N-2,N-2-diacylated products.
查看更多